210 related articles for article (PubMed ID: 28479419)
1. Novel tumor-suppressor function of KLF4 in pediatric T-cell acute lymphoblastic leukemia.
Shen Y; Chen TJ; Lacorazza HD
Exp Hematol; 2017 Sep; 53():16-25. PubMed ID: 28479419
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of KLF4 promotes T-cell acute lymphoblastic leukemia and activates the MAP2K7 pathway.
Shen Y; Park CS; Suppipat K; Mistretta TA; Puppi M; Horton TM; Rabin K; Gray NS; Meijerink JPP; Lacorazza HD
Leukemia; 2017 Jun; 31(6):1314-1324. PubMed ID: 27872496
[TBL] [Abstract][Full Text] [Related]
3. miR-2909-mediated regulation of KLF4: a novel molecular mechanism for differentiating between B-cell and T-cell pediatric acute lymphoblastic leukemias.
Malik D; Kaul D; Chauhan N; Marwaha RK
Mol Cancer; 2014 Jul; 13():175. PubMed ID: 25037230
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide analyses identify KLF4 as an important negative regulator in T-cell acute lymphoblastic leukemia through directly inhibiting T-cell associated genes.
Li W; Jiang Z; Li T; Wei X; Zheng Y; Wu D; Yang L; Chen S; Xu B; Zhong M; Jiang J; Hu Y; Su H; Zhang M; Huang X; Geng S; Weng J; Du X; Liu P; Li Y; Liu H; Yao Y; Li P
Mol Cancer; 2015 Feb; 14():26. PubMed ID: 25644173
[TBL] [Abstract][Full Text] [Related]
5. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways.
Scupoli MT; Donadelli M; Cioffi F; Rossi M; Perbellini O; Malpeli G; Corbioli S; Vinante F; Krampera M; Palmieri M; Scarpa A; Ariola C; Foà R; Pizzolo G
Haematologica; 2008 Apr; 93(4):524-32. PubMed ID: 18322253
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the MAP2K7-JNK pathway with 5Z-7-oxozeaenol induces apoptosis in T-cell acute lymphoblastic leukemia.
Chen TJ; Du W; Junco JJ; Bridges CS; Shen Y; Puppi M; Rabin KR; Lacorazza HD
Oncotarget; 2021 Aug; 12(18):1787-1801. PubMed ID: 34504651
[TBL] [Abstract][Full Text] [Related]
8. Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells.
Martelli AM; Lonetti A; Buontempo F; Ricci F; Tazzari PL; Evangelisti C; Bressanin D; Cappellini A; Orsini E; Chiarini F
Adv Biol Regul; 2014 Sep; 56():6-21. PubMed ID: 24819383
[TBL] [Abstract][Full Text] [Related]
9. Loss of tumor suppressor p53 decreases PTEN expression and enhances signaling pathways leading to activation of activator protein 1 and nuclear factor kappaB induced by UV radiation.
Wang J; Ouyang W; Li J; Wei L; Ma Q; Zhang Z; Tong Q; He J; Huang C
Cancer Res; 2005 Aug; 65(15):6601-11. PubMed ID: 16061640
[TBL] [Abstract][Full Text] [Related]
10. Mitogen-activated protein kinase is required for bryostatin 1-induced differentiation of the human acute lymphoblastic leukemia cell line Reh.
Wall NR; Mohammad RM; Al-Katib AM
Cell Growth Differ; 2001 Dec; 12(12):641-7. PubMed ID: 11751459
[TBL] [Abstract][Full Text] [Related]
11. JNK/AP-1 activation contributes to tetrandrine resistance in T-cell acute lymphoblastic leukaemia.
Liou JT; Lin CS; Liao YC; Ho LJ; Yang SP; Lai JH
Acta Pharmacol Sin; 2017 Aug; 38(8):1171-1183. PubMed ID: 28603286
[TBL] [Abstract][Full Text] [Related]
12. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
Chen ZY; Tseng CC
Mol Pharmacol; 2005 Nov; 68(5):1203-13. PubMed ID: 16077033
[TBL] [Abstract][Full Text] [Related]
13. Antileukemic properties of the kinase inhibitor OTSSP167 in T-cell acute lymphoblastic leukemia.
Bridges CS; Chen TJ; Puppi M; Rabin KR; Lacorazza HD
Blood Adv; 2023 Feb; 7(3):422-435. PubMed ID: 36399528
[TBL] [Abstract][Full Text] [Related]
14. ATRA activates and PDGF-BB represses the SM22α promoter through KLF4 binding to, or dissociating from, its cis-DNA elements.
Yu K; Zheng B; Han M; Wen JK
Cardiovasc Res; 2011 Jun; 90(3):464-74. PubMed ID: 21252119
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy.
Sengupta TK; Leclerc GM; Hsieh-Kinser TT; Leclerc GJ; Singh I; Barredo JC
Mol Cancer; 2007 Jul; 6():46. PubMed ID: 17623090
[TBL] [Abstract][Full Text] [Related]
16. KLF4 regulates adult lung tumor-initiating cells and represses K-Ras-mediated lung cancer.
Yu T; Chen X; Zhang W; Liu J; Avdiushko R; Napier DL; Liu AX; Neltner JM; Wang C; Cohen D; Liu C
Cell Death Differ; 2016 Feb; 23(2):207-15. PubMed ID: 26113043
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].
Lu XT
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):327-32. PubMed ID: 23591360
[TBL] [Abstract][Full Text] [Related]
18. The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia.
Mendes RD; Canté-Barrett K; Pieters R; Meijerink JP
Haematologica; 2016 Sep; 101(9):1010-7. PubMed ID: 27582570
[TBL] [Abstract][Full Text] [Related]
19. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
[TBL] [Abstract][Full Text] [Related]
20. Busulfan selectively induces cellular senescence but not apoptosis in WI38 fibroblasts via a p53-independent but extracellular signal-regulated kinase-p38 mitogen-activated protein kinase-dependent mechanism.
Probin V; Wang Y; Bai A; Zhou D
J Pharmacol Exp Ther; 2006 Nov; 319(2):551-60. PubMed ID: 16882877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
